glp-1 stomach acid Gastrointestinal effects of receptor agonists: mechanisms, management, and future directions Designing GLP-1 delivery: structural perspectives

Development of a 96-well based assay for kinetic determination of catalase enzymatic-activity in biological samples

J Allergy Clin Immunol Pract 7(6):186873e5 Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M et al (2016) Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

(2017) 12:e0179538

Remove extra skin

Biochem J 417, 113 (2009)

CVOTs evaluating GLP-1 receptor agonists (GLP-1 RA) effects on cardiovascular outcomes have consistently shown a reduction in MACE rates, primarily in rates of non-fatal myocardial infarction, non-fatal stroke and cardiovascular death